3 Biotechnology Stocks to Sell Now

Advertisement

The ratings of three Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

This week, Keryx Biopharmaceuticals (NASDAQ:KERX) falls to a D (“sell”), worse than last week’s grade of C (“hold”). Keryx Biopharmaceuticals focuses on developing and commercializing pharmaceuticals for the treatment of cancer and renal disease. In Portfolio Grader’s specific subcategories of Equity, Cash Flow, and Sales Growth, KERX also gets an F. As of Sept. 5, 15% of outstanding Keryx Biopharmaceuticals shares were held short. For a full analysis of KERX stock, visit Portfolio Grader.

This week, Sinovac Biotech‘s (NASDAQ:SVA) rating worsens to a D from the company’s C rating a week ago. Sinovac Biotech researches, develops, manufactures, and markets various vaccines, including flu vaccines and vaccines for Hepatitis A. The stock gets F’s in Equity and Cash Flow. In the past week, trade volume fell significantly to half the previous rate. To get an in-depth look at SVA, get Portfolio Grader’s complete analysis of SVA stock.

Enzon Pharmaceuticals (NASDAQ:ENZN) ratings are on the decline this week as the company earns an F (“strong sell”). Last week, it received a D (“sell”). Enzon Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The stock also gets an F in Equity. Shares of the stock are changing hands at twice the rate they were a week ago. For more information, get Portfolio Grader’s complete analysis of ENZN stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2012/09/3-biotechnology-stocks-to-sell-now-kerx-sva-enzn/.

©2024 InvestorPlace Media, LLC